Formoterol and mometasone aerosol formulations
US8252268B2 · kind B2 · utility
16Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2003 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Oct 2, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/124
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical aerosol formulation comprising particles of (a) formoterol or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof and (b) mometasone or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof dispersed in a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof, and a bulking agent having a mass median diameter of less than one micron.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.